Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl

Nature Structural and Molecular Biology

Volumn 19, Issue 2, 2012, Pages 184-192

  Dou, Hao ^a   Buetow, Lori ^a   Hock, Andreas ^a   Sibbet, Gary J ^a   Vousden, Karen H ^a   Huang, Danny T ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CBL PROTEIN; PROTEIN TYROSINE KINASE; RING FINGER PROTEIN; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME E2;

ARTICLE; BINDING AFFINITY; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENZYME BINDING; HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CRYSTALLOGRAPHY, X-RAY; HUMANS; MODELS, MOLECULAR; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-CBL;

EID: 84856708226     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.2231     Document Type: Article

References (51)

1. Hershko, A. & Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 67, 425-479 (1998). (Pubitemid 28411135)
2. Pickart, C.M. & Eddins, M.J. Ubiquitin: structures, functions, mechanisms. Biochim. Biophys. Acta 1695, 55-72 (2004). (Pubitemid 39585154)
3. Dye, B.T. & Schulman, B.A. Structural mechanisms underlying posttranslational modification by ubiquitin-like proteins. Annu. Rev. Biophys. Biomol. Struct. 36, 131-150 (2007). (Pubitemid 46998113)
4. Duda, D.M. et al. Structural regulation of cullin-RING ubiquitin ligase complexes. Curr. Opin. Struct. Biol. 21, 257-264 (2011).
5. Deshaies, R.J. & Joazeiro, C.A. RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78, 399-434 (2009).
6. Li, W. et al. Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle′s dynamics and signaling. PLoS ONE 3, e1487 (2008).
7. Joazeiro, C.A. et al. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286, 309-312 (1999).
8. Levkowitz, G. et al. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol. Cell 4, 1029-1040 (1999). (Pubitemid 30054908)
9. Schmidt, M.H. & Dikic, I. The Cbl interactome and its functions. Nat. Rev. Mol. Cell Biol. 6, 907-918 (2005). (Pubitemid 41778710)
10. Swaminathan, G. & Tsygankov, A.Y. The Cbl family proteins: ring leaders in regulation of cell signaling. J. Cell. Physiol. 209, 21-43 (2006). (Pubitemid 44318665)
11. Yoon, C.H., Lee, J., Jongeward, G.D. & Sternberg, P.W. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl. Science 269, 1102-1105 (1995).
12. Peschard, P. et al. Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b. Mol. Cell 27, 474-485 (2007). (Pubitemid 47126940)
13. Kozlov, G. et al. Structural basis for UBA-mediated dimerization of c-Cbl ubiquitin ligase. J. Biol. Chem. 282, 27547-27555 (2007). (Pubitemid 47501924)
14. Lupher, M.L. Jr., Songyang, Z., Shoelson, S.E., Cantley, L.C. & Band, H. The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70. J. Biol. Chem. 272, 33140-33144 (1997). (Pubitemid 28023658)
15. Meng, W., Sawasdikosol, S., Burakoff, S.J. & Eck, M.J. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. Nature 398, 84-90 (1999).
16. Zheng, N., Wang, P., Jeffrey, P.D. & Pavletich, N.P. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102, 533-539 (2000).
17. Andoniou, C.E., Thien, C.B. & Langdon, W.Y. Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. EMBO J. 13, 4515-4523 (1994). (Pubitemid 24310201)
18. Blake, T.J., Shapiro, M., Morse, H.C. III & Langdon, W.Y. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene 6, 653-657 (1991). (Pubitemid 21924132)
19. Bisson, S.A., Ujack, E.E. & Robbins, S.M. Isolation and characterization of a novel, transforming allele of the c-Cbl proto-oncogene from a murine macrophage cell line. Oncogene 21, 3677-3687 (2002). (Pubitemid 34620531)
20. Thien, C.B., Walker, F. & Langdon, W.Y. RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation. Mol. Cell 7, 355-365 (2001). (Pubitemid 32206503)
21. Sanada, M. et al. Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms. Nature 460, 904-908 (2009).
22. Niemeyer, C.M. et al. Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nat. Genet. 42, 794-800 (2010).
23. Grand, F.H. et al. Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms. Blood 113, 6182-6192 (2009).
24. Kales, S.C., Ryan, P.E., Nau, M.M. & Lipkowitz, S. Cbl and human myeloid neoplasms: the Cbl oncogene comes of age. Cancer Res. 70, 4789-4794 (2010).
25. Kassenbrock, C.K. & Anderson, S.M. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations. J. Biol. Chem. 279, 28017-28027 (2004). (Pubitemid 38900072)
26. Ryan, P.E., Sivadasan-Nair, N., Nau, M.M., Nicholas, S. & Lipkowitz, S. The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme. J. Biol. Chem. 285, 23687-23698 (2010).
27. Zhang, Y. et al. Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol. Cell. Proteomics 4, 1240-1250 (2005). (Pubitemid 41448712)
28. Liu, J., Kimura, A., Baumann, C.A. & Saltiel, A.R. APS facilitates c-Cbl tyrosine phosphorylation and GLUT4 translocation in response to insulin in 3T3-L1 adipocytes. Mol. Cell. Biol. 22, 3599-3609 (2002). (Pubitemid 34525204)
29. Hu, J. & Hubbard, S.R. Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins. J. Biol. Chem. 280, 18943-18949 (2005). (Pubitemid 41379597)
30. Ng, C. et al. Structural basis for a novel intrapeptidyl H-bond and reverse binding of c-Cbl-TKB domain substrates. EMBO J. 27, 804-816 (2008). (Pubitemid 351506681)
31. Dominguez, C. et al. Structural model of the UbcH5B/CNOT4 complex revealed by combining NMR, mutagenesis, and docking approaches. Structure 12, 633-644 (2004). (Pubitemid 38447166)
32. Mace, P.D. et al. Structures of the cIAP2 RING domain reveal conformational changes associated with ubiquitin-conjugating enzyme (E2) recruitment. J. Biol. Chem. 283, 31633-31640 (2008).
33. Brzovic, P.S. et al. Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. Proc. Natl. Acad. Sci. USA 100, 5646-5651 (2003). (Pubitemid 36576862)
34. Buchwald, G. et al. Structure and E3-ligase activity of the Ring-Ring complex of polycomb proteins Bmi1 and Ring1b. EMBO J. 25, 2465-2474 (2006). (Pubitemid 44012229)
35. Visser Smit, G.D. et al. Cbl controls EGFR fate by regulating early endosome fusion. Sci. Signal. 2, ra86 (2009).
36. Ryan, P.E., Davies, G.C., Nau, M.M. & Lipkowitz, S. Regulating the regulator: negative regulation of Cbl ubiquitin ligases. Trends Biochem. Sci. 31, 79-88 (2006). (Pubitemid 43221840)
37. Saha, A. & Deshaies, R.J. Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation. Mol. Cell 32, 21-31 (2008).
38. Siepmann, T.J., Bohnsack, R.N., Tokgoz, Z., Baboshina, O.V. & Haas, A.L. Protein interactions within the N-end rule ubiquitin ligation pathway. J. Biol. Chem. 278, 9448-9457 (2003). (Pubitemid 36800436)
39. Song, J.J. et al. c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistance. Cell. Signal. 22, 553-563 (2010).
40. Yokouchi, M. et al. Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins. J. Biol. Chem. 276, 35185-35193 (2001).
41. Pufall, M.A. & Graves, B.J. Autoinhibitory domains: modular effectors of cellular regulation. Annu. Rev. Cell Dev. Biol. 18, 421-462 (2002). (Pubitemid 35387357)
42. Zhang, M. et al. Chaperoned ubiquitylation-crystal structures of the CHIP U box E3 ubiquitin ligase and a CHIP-Ubc13-Uev1a complex. Mol. Cell 20, 525-538 (2005). (Pubitemid 41668638)
43. Du, F., Navarro-Garcia, F., Xia, Z., Tasaki, T. & Varshavsky, A. Pairs of dipeptides synergistically activate the binding of substrate by ubiquitin ligase through dissociation of its autoinhibitory domain. Proc. Natl. Acad. Sci. USA 99, 14110-14115 (2002). (Pubitemid 35257633)
44. Lopez, J. et al. CARD-mediated autoinhibition of cIAP1′s E3 ligase activity suppresses cell proliferation and migration. Mol. Cell 42, 569-583 (2011).
45. Chaugule, V.K. et al. Autoregulation of Parkin activity through its ubiquitin-like domain. EMBO J. 30, 2853-2867 (2011).
46. Yamoah, K. et al. Autoinhibitory regulation of SCF-mediated ubiquitination by human cullin 1′s C-terminal tail. Proc. Natl. Acad. Sci. USA 105, 12230-12235 (2008).
47. Duda, D.M. et al. Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell 134, 995-1006 (2008).
48. Gallagher, E., Gao, M., Liu, Y.C. & Karin, M. Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change. Proc. Natl. Acad. Sci. USA 103, 1717-1722 (2006). (Pubitemid 43228759)
49. Wiesner, S. et al. Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain. Cell 130, 651-662 (2007). (Pubitemid 47268058)
50. Goldenberg, S.J. et al. Structure of the Cand1-Cul1-Roc1 complex reveals regulatory mechanisms for the assembly of the multisubunit cullin-dependent ubiquitin ligases. Cell 119, 517-528 (2004). (Pubitemid 39482351)
51. Kobashigawa, Y. et al. Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b. Proc. Natl. Acad. Sci. USA 108, 20579-20584 (2011).